The Pallanti Method is a method of Translational, Clinical Neuroscience, a systematic approach to health care through the analysis and translation of clinical symptoms into their functional meaning.
Dr. Pallanti’s first priority requires that he listens to what the patient says and how the patient tells his story, whence he translates the discourse to unveil the dynamics of distress in relation to the patient’s biography and brain functioning, evidenced by objective evaluations.
He integrates and coordinates the patient’s subjective history with research on the substrate brain circuit upon which every medical, pharmacological, and non-pharmacological intervention depends and acts.
He learns from every patient about unique connections between psychiatric symptoms and their medical and genetic conditions that help to advance his knowledge in basic medical science.
The starting point lies in the definition of the diagnosis: the symptom does not define the diagnosis, and the diagnosis does not establish the cure. The diagnosis of the Pallanti Method goes beyond the traditional classification of behavioral disorders: it considers the health condition of a person as a whole, often using II and III level instruments.
Once the diagnosis is defined, Dr. Pallanti has a precise idea of the dimension of the disorder and the circuits by which he may guide the treatment.
He chooses the treatment option aimed at modifying the functional level of a person and not just that person’s behavior. Together with the patient, Dr. Pallanti establishes the sequential priority of care, most suitable treatment for each person in his or her particular moment of life, based on precision psychiatry.
The professional ethics of the Pallanti Method are holistic and focus on the person understood in his versatility of everyday life, working life, relationships, and perspectives.
The Pallanti Method seeks to reconcile a total respect for the person and the use of cutting-edge techniques and therapies, useful for improving performance and preventing long-term disorders.
Neuroscience applied to treatments
High Ethical Value
Professor of Psychiatry, Albert Einstein College of Medicine and Montefiore Medical Center, New York (USA)
Visiting Professor of Psychiatry, Imperial College, London (UK)
Faculty, Harvard University and Massachussetts General Hospital Psychiatry Academy (USA)
Faculty, Training School at Clare College, Cambridge University (UK)
Board Member of the European Commission, Consensus Initiative for Depression and its Treatments (EU PEARL)
The World Health Organization expert on anxiety
World Health Organization funded COVID-19 Clinical Research Coalition’s Ethics Working Group, the Good Clinical Practice Alliance – Europe (GCPA)